Patents by Inventor Sally Ellen Wenzel

Sally Ellen Wenzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage Form for Treating Severe Asthma
    Publication number: 20220062322
    Abstract: Methods are provided for treating corticosteroid-resistant asthma in a patient, comprising decreasing Interferon Regulatory Factor 5 (IRF5) activity in the patient. Antisense or RNA interference reagents and methods can be used to decrease IRF5 activity in the patient.
    Type: Application
    Filed: September 3, 2021
    Publication date: March 3, 2022
    Inventors: Anuradha Ray, Prabir Ray, Sally Ellen Wenzel, Timothy B. Oriss
  • Dosage form for treating severe asthma
    Patent number: 11129846
    Abstract: Methods are provided for treating corticosteroid-resistant asthma in a patient, comprising decreasing Interferon Regulatory Factor 5 (IRF5) activity in the patient. Antisense or RNA interference reagents and methods can be used to decrease IRF5 activity in the patient.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: September 28, 2021
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Anuradha Ray, Prabir Ray, Timothy B. Oriss, Sally Ellen Wenzel
  • Dosage Form for Treating Severe Asthma
    Publication number: 20190388455
    Abstract: Methods are provided for treating corticosteroid-resistant asthma in a patient, comprising decreasing Interferon Regulatory Factor 5 (IRF5) activity in the patient. Antisense or RNA interference reagents and methods can be used to decrease IRF5 activity in the patient.
    Type: Application
    Filed: August 13, 2019
    Publication date: December 26, 2019
    Inventors: Anuradha Ray, Prabir Ray, Timothy B. Oriss, Sally Ellen Wenzel
  • Method of treating severe asthma
    Patent number: 10420792
    Abstract: Methods are provided for treating corticosteroid-resistant asthma in a patient, comprising decreasing Interferon Regulatory Factor 5 (IRF5) activity in the patient. Antisense or RNA interference reagents and methods can be used to decrease IRF5 activity in the patient.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: September 24, 2019
    Assignee: The University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Anuradha Ray, Prabir Ray, Sally Ellen Wenzel, Timothy B. Oriss
  • Method of Treating Severe Asthma
    Publication number: 20180243330
    Abstract: Methods are provided for treating corticosteroid-resistant asthma in a patient, comprising decreasing Interferon Regulatory Factor 5 (IRF5) activity in the patient. Antisense or RNA interference reagents and methods can be used to decrease IRF5 activity in the patient.
    Type: Application
    Filed: February 23, 2018
    Publication date: August 30, 2018
    Inventors: Anuradha Ray, Prabir Ray, Sally Ellen Wenzel, Timothy B. Oriss